4.5 Article

Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells

期刊

INTERNATIONAL IMMUNOLOGY
卷 20, 期 4, 页码 565-575

出版社

OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxn014

关键词

glucocorticoids; lymphocyte differentiation; NK cells

资金

  1. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

向作者/读者索取更多资源

Previous studies showed that methylprednisolone (MePDN) down-regulates the surface expression of activating NK receptors and sharply inhibits the NK cytotoxicity both in vitro and in vivo. Since MePDN is administered to patients undergoing hemopoietic stem cell transplant to treat acute graft versus host disease (GvHD), we analyzed whether it could also inhibit the NK cell differentiation from CD34(+) hemopoietic cell precursors, thus interfering with the development of effector cells with anti-leukemic potential. We show that MePDN promotes the in vitro differentiation of CD161(+)CD56(+/-) immature NK cells by inducing a rapid expression of NKp46, NKG2D, DNAX-accessory molecule 1 (DNAM-1), leukocyte function-associated antigen-1 and NKG2A and an efficient cytolytic activity. This phenotypic and functional NK cell maturation occurred more rapidly than in parallel control cultures performed in the absence of MePDN. In addition, MePDN induced CD33(+)CD161(-)CD56(-) myeloid precursors to switch toward NK cells. It is also of note that immature NK cells when cultured in the absence (but not in the presence) of MePDN produced high amounts of IL-8. These data indicate that MePDN can accelerate the in vitro NK cell differentiation, thus revealing a dichotomous effect on immature versus mature NK cells; in addition, interference with the in vitro development of myeloid cells occurred. These effects should be further investigated in hemopoietic stem cell transplanted patients receiving steroids to treat GvHD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Correction Immunology

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines (vol 49, 971, 2019)

Nadia Caccamo, Gabriella Pietra, Lucy C. Sullivan, Andrew G. Brooks, Teresa Prezzemolo, Marco P. La Manna, Diana Di Liberto, Simone A. Joosten, Krista E. van Meijgaarden, Paola Di Carlo, Lucina Titone, Lorenzo Moretta, Maria C. Mingari, Tom H. M. Ottenhoff, Francesco Dieli

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Letter Oncology

PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation

Nicola Tumino, Francesca Besi, Anna Laura Di Pace, Francesca Romana Mariotti, Pietro Merli, Giuseppina Li Pira, Federica Galaverna, Angela Pitisci, Tiziano Ingegnere, Andrea Pelosi, Linda Quatrini, Enrico Munari, Franco Locatelli, Lorenzo Moretta, Paola Vacca

LEUKEMIA (2020)

Article Allergy

Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells

Linda Quatrini, Paola Vacca, Nicola Tumino, Francesca Besi, Anna Laura Di Pace, Francesca Scordamaglia, Stefania Martini, Enrico Munari, Maria Cristina Mingari, Sophie Ugolini, Lorenzo Moretta

Summary: The induction of PD-1 expression on human NK cells in the tumor setting is dependent on the cooperative action of glucocorticoids and cytokines, leading to enhanced mRNA translation and increased PD-1 levels.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

NK cells and ILCs in tumor immunotherapy

Simona Sivori, Daniela Pende, Linda Quatrini, Gabriella Pietra, Mariella Della Chiesa, Paola Vacca, Nicola Tumino, Francesca Moretta, Maria Cristina Mingari, Franco Locatelli, Lorenzo Moretta

Summary: Innate immune cells, especially NK cells, play an important role in tumor immunotherapy by controlling tumor growth and metastasis. Various approaches have been developed, such as using IL-15 to improve NK cell function and utilizing NK cell engagers to activate NK cells. Additionally, NK cells may express inhibitory checkpoints like PD-1, which can be targeted for therapeutic use against certain tumors.

MOLECULAR ASPECTS OF MEDICINE (2021)

Article Oncology

Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia

Raffaella Meazza, Michela Falco, Fabrizio Loiacono, Paolo Canevali, Mariella Della Chiesa, Alice Bertaina, Daria Pagliara, Pietro Merli, Valentina Indio, Federica Galaverna, Mattia Algeri, Francesca Moretta, Natalia Colomar-Carando, Letizia Muccio, Simona Sivori, Andrea Pession, Maria Cristina Mingari, Lorenzo Moretta, Alessandro Moretta, Franco Locatelli, Daniela Pende

CANCERS (2020)

Editorial Material Oncology

TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is Better

Gabriella Pietra, Maria Cristina Mingari, Lorenzo Moretta

CLINICAL CANCER RESEARCH (2020)

Review Immunology

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease

Linda Quatrini, Nicola Tumino, Francesca Moretta, Francesca Besi, Paola Vacca, Lorenzo Moretta

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer

Simona Sivori, Mariella Della Chiesa, Simona Carlomagno, Linda Quatrini, Enrico Munari, Paola Vacca, Nicola Tumino, Francesca Romana Mariotti, Maria Cristina Mingari, Daniela Pende, Lorenzo Moretta

FRONTIERS IN IMMUNOLOGY (2020)

Article Oncology

EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34+ Cells

Laura Damele, Adriana Amaro, Alberto Serio, Silvia Luchetti, Ulrich Pfeffer, Maria Cristina Mingari, Chiara Vitale

Summary: EZH1/2 enzymes play a critical role in tumor development and hematopoiesis, with inhibitors potentially affecting NK cell differentiation and function. Clinical trials on EZH1/2 inhibitors against solid tumors are ongoing, but these inhibitors may also impact hematopoietic stem/progenitor cells and the generation of anti-tumor lymphocytes.

CANCERS (2021)

Review Immunology

Determinants, mechanisms, and outcomes of myeloid cell diversity in cancer

Nicoletta Caronni, Elisa Montaldo, Luca Mezzanzanica, Francesco Cilenti, Marco Genua, Renato Ostuni

Summary: The development of cancer is influenced by the tumor microenvironment, and advancements in single-cell analysis technologies have helped unravel the contributions of the immune system to cancer progression. Tumor-associated macrophages and neutrophils play crucial roles in disrupting immune homeostasis and providing therapeutic opportunities for reprogramming the tumor microenvironment.

IMMUNOLOGICAL REVIEWS (2021)

Article Immunology

A PGE2-MEF2A axis enables context-dependent control of inflammatory gene expression

Francesco Cilenti, Giulia Barbiera, Nicoletta Caronni, Dario Iodice, Elisa Montaldo, Simona Barresi, Eleonora Lusito, Vincenzo Cuzzola, Francesco Maria Vittoria, Luca Mezzanzanica, Paolo Miotto, Pietro Di Lucia, Dejan Lazarevic, Daniela Maria Cirillo, Matteo Iannacone, Marco Genua, Renato Ostuni

Summary: Tightly controlling inflammatory gene expression by antagonistic environmental signals is crucial for immune protection and tissue damage prevention. PGE(2) modulates macrophage activation and interferes with LPS-induced gene expression through targeting the MEF2A-ERK5 interaction, impacting IFN I induction.

IMMUNITY (2021)

Article Ophthalmology

Is there a role for tapered topical dose steroidal treatment for dry eye disease? A randomized, pilot study

Stefano Barabino, Elisa Montaldo, Maria Cristina Mingari, Cosimo Mazzotta, Sebastiano Giuffrida, Maurizio Rolando

Summary: The study demonstrated that tapered doses of loteprednol etabonate effectively reduced dry eye symptoms and improved ocular surface inflammation, while maintaining intraocular pressure and best corrected visual acuity.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)

Article Immunology

Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress

Elisa Montaldo, Eleonora Lusito, Valentina Bianchessi, Nicoletta Caronni, Serena Scala, Luca Basso-Ricci, Carla Cantaffa, Alice Masserdotti, Mattia Barilaro, Simona Barresi, Marco Genua, Francesco Maria Vittoria, Giulia Barbiera, Dejan Lazarevic, Carlo Messina, Elisabetta Xue, Sarah Marktel, Cristina Tresoldi, Raffaella Milani, Paola Ronchi, Salvatore Gattillo, Luca Santoleri, Raffaella Di Micco, Andrea Ditadi, Giulio Belfiori, Francesca Aleotti, Matteo Maria Naldini, Bernhard Gentner, Elisa Gardiman, Nicola Tamassia, Marco Antonio Cassatella, Andres Hidalgo, Immanuel Kwok, Lai Guan Ng, Stefano Crippa, Massimo Falconi, Francesca Pettinella, Patrizia Scapini, Luigi Naldini, Fabio Ciceri, Alessandro Aiuti, Renato Ostuni

Summary: Recent studies have found that human neutrophils exhibit substantial function diversity. This study performs immunophenotyping and transcriptome analysis to characterize the heterogeneity of human neutrophils under steady state and stress-induced conditions. The researchers uncover an extreme diversity of human neutrophils in vivo, reflecting the rates of cell mobilization, differentiation, and exposure to environmental signals. The findings suggest that systematic characterization of neutrophil plasticity may lead to the discovery of clinically relevant biomarkers and the development of diagnostic and therapeutic tools.

NATURE IMMUNOLOGY (2022)

Review Oncology

Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?

Laura Damele, Grazia Maria Spaggiari, Monica Parodi, Maria Cristina Mingari, Massimo Vitale, Chiara Vitale

Summary: NK cells have established anti-tumor activity against hematological malignancies and their role in controlling solid tumor growth and metastasis generation is supported by many studies. However, the tumor microenvironment may influence NK cell function. In this context, umbilical cord blood (UCB) is an important source of NK cells and CD34(+) HSPCs, which can generate NK cells. UCB-derived NK cells are valuable for in vitro and preclinical analyses and have been used in clinical settings against hematological malignancies. This review summarizes the characteristics of UCB-derived NK cells and the in vitro models for their expansion, highlighting their importance in cancer immunotherapy protocols.

CANCERS (2022)

Review Oncology

The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy

Linda Quatrini, Francesca Romana Mariotti, Enrico Munari, Nicola Tumino, Paola Vacca, Lorenzo Moretta

CANCERS (2020)

暂无数据